Page last updated: 2024-09-05

erlotinib hydrochloride and pyrene

erlotinib hydrochloride has been researched along with pyrene in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)
Trials
(erlotinib hydrochloride)
Recent Studies (post-2010)
(erlotinib hydrochloride)
Studies
(pyrene)
Trials
(pyrene)
Recent Studies (post-2010) (pyrene)
4,3537863,0332,16331,072

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)pyrene (IC50)
Cytochrome P450 1A1Homo sapiens (human)0.041
Cytochrome P450 1A2Homo sapiens (human)0.007
Cytochrome P450 1B1Homo sapiens (human)0.002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jafarirad, S; Namazi, H1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and pyrene

ArticleYear
In vitro photo-controlled drug release system based on amphiphilic linear-dendritic diblock copolymers; self-assembly behavior and application as nanocarrier.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2011, Volume: 14, Issue:2

    Topics: Azo Compounds; Biological Availability; Chromatography, Gel; Delayed-Action Preparations; Drug Carriers; Erlotinib Hydrochloride; Isomerism; Light; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Electron; Particle Size; Photochemical Processes; Polyethylene Glycols; Polymers; Protein Kinase Inhibitors; Pyrenes; Quinazolines; Scattering, Radiation; Siloxanes; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Ultraviolet Rays

2011